• Communities & Collections
    • By Issue Date
    • Authors
    • Titles
    • Subjects
    • Document type
    • español
    • English
    • português (Brasil)
  • Self archiving
  • Browse 
    • Communities & Collections
    • By Issue Date
    • Authors
    • Titles
    • Subjects
    • Document type
  • English 
    • español
    • English
    • português (Brasil)
  • Login
View Item 
  •   Institutional repository ITM
  • Investigación
  • Artículos
  • View Item
  •   Institutional repository ITM
  • Investigación
  • Artículos
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

Browse

All of ITMCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsDocument typeThis CollectionBy Issue DateAuthorsTitlesSubjectsDocument type

My Account

LoginRegister

Statistics

View Usage Statistics
Statistics GTMView statistics GTM

Bevacizumab as a treatment option in gastrointestinal bleeding associated to hereditary hemorrhagic telangiectasia. Case Report [Bevacizumab como opción terapéutica en sangrado gastrointestinal asociado a telangiectasia hemorrágica hereditaria. Reporte de caso]

Thumbnail
QRCode
Share this
Bevacizumab as a treatment option in gastrointestinal bleeding associated to hereditary hemorrhagic telangiectasia. Case Report [Bevacizumab como opción terapéutica en sangrado gastrointestinal asociado a telangiectasia hemorrágica hereditaria. Reporte de caso]
Date
2019
Author
Castillo E.
Prada-Arismendy J.

Citation

       
TY - GEN T1 - Bevacizumab as a treatment option in gastrointestinal bleeding associated to hereditary hemorrhagic telangiectasia. Case Report [Bevacizumab como opción terapéutica en sangrado gastrointestinal asociado a telangiectasia hemorrágica hereditaria. Reporte de caso] AU - Castillo E. AU - Prada-Arismendy J. Y1 - 2019 UR - http://hdl.handle.net/20.500.12622/3143 AB - ER - @misc{20.500.12622_3143, author = {Castillo E. and Prada-Arismendy J.}, title = {Bevacizumab as a treatment option in gastrointestinal bleeding associated to hereditary hemorrhagic telangiectasia. Case Report [Bevacizumab como opción terapéutica en sangrado gastrointestinal asociado a telangiectasia hemorrágica hereditaria. Reporte de caso]}, year = {2019}, abstract = {}, url = {http://hdl.handle.net/20.500.12622/3143} }RT Generic T1 Bevacizumab as a treatment option in gastrointestinal bleeding associated to hereditary hemorrhagic telangiectasia. Case Report [Bevacizumab como opción terapéutica en sangrado gastrointestinal asociado a telangiectasia hemorrágica hereditaria. Reporte de caso] A1 Castillo E. A1 Prada-Arismendy J. YR 2019 LK http://hdl.handle.net/20.500.12622/3143 AB OL Spanish (121)
Bibliographic managers
Refworks
Zotero
BibTeX
CiteULike
Metadata
Show full item record
Source
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85073739486&doi=10.15446%2frevfacmed.v67n3.68417&partnerID=40&md5=7c45a39e018fe8d40526746065db9a08
URI
http://hdl.handle.net/20.500.12622/3143
DOI
https://doi.org/10.15446/revfacmed.v67n3.68417
Statistics Google Analytics
Collections
  • Artículos [930]

Departamento de Biblioteca y Extensión Cultural
bibliotecaitm@itm.edu.co

Contact Us | Send Feedback